Lyubuchany, Russia

Olga Vladimirovna Goncharova

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Closed Joint Stock Company “Biocad”, Other. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olga Vladimirovna Goncharova. Retrieved from https://idiyas.com/inventor/olga-vladimirovna-goncharova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 75.0


 

Average Co-Inventor Count = 12.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Lyubuchany Chekhovskiy r-n Moskovskaya.obl, RU (2019)
  • (2021)
  • Lyubuchany, RU (2019 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Olga Vladimirovna Goncharova: Innovator in Biotechnology

Introduction

Olga Vladimirovna Goncharova is a prominent inventor based in Lyubuchany, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

One of her latest patents is titled "Method for treatment of an IL-17A-mediated disease through antibody administration specific to human IL-17A." This invention involves monoclonal IgG-type antibodies that include variable domains represented by a combination of VHH-derivative with a variable domain of the light chain V. The antibodies possess increased affinity and improved aggregation stability due to amino acid substitutions at specific positions.

Another significant patent is "Anti-PD-1 antibodies, method for producing same and method for using same." This invention relates to isolated monoclonal antibodies that specifically bind to PD-1 with high affinity. These antibodies can be chimeric, humanized, or human antibodies, and are intended for use as medicinal agents in oncology and immuno-oncology. The patent also covers methods for producing these antibodies and their application in treating human diseases.

Career Highlights

Throughout her career, Goncharova has worked with various organizations, including Biocad, a well-known biotechnology company. Her innovative work in antibody development has positioned her as a key figure in the field.

Collaborations

Goncharova has collaborated with notable professionals in her field, including Timofey Aleksandrovich Nemankin and Andrey Borisovich Ulitin. These collaborations have further enhanced her research and development efforts.

Conclusion

Olga Vladimirovna Goncharova is a distinguished inventor whose work in biotechnology, particularly in monoclonal antibodies, showcases her innovative spirit and dedication to advancing medical science. Her contributions are likely to have a lasting impact on the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…